$VYCO
Vycor Medical Inc Stock $vyco

$vyco Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222031733 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$271.3K	$310.0K	$332.1K
YoY Change	-0.9%	-6.66%	20.35%
Cost Of Revenue	$37.15K	$42.20K	$35.15K
YoY Change	16.9%	20.05%	-13.32%
Gross Profit	$234.1K	$267.8K	$296.9K
YoY Change	-3.24%	-9.82%	26.15%
Gross Profit Margin	86.3%	86.39%	89.42%
Selling, General & Admin	$310.9K	$341.3K	$365.8K
YoY Change	-18.74%	-6.71%	-14.39%
% of Gross Profit	132.81%	127.44%	123.19%
Research & Development	$0.00		$1.830K
YoY Change	-100.0%
% of Gross Profit	0.0%		0.62%
Depreciation & Amortization	$15.33K	$14.56K	$18.39K
YoY Change	-13.73%	-20.83%	26.39%
% of Gross Profit	6.55%	5.44%	6.19%
Operating Expenses	$325.3K	$355.8K	$385.3K
YoY Change	-19.9%	-7.66%
Operating Profit	-$91.20K	-$88.05K	-$88.39K
YoY Change	-44.46%	-0.39%	-137.55%
Interest Expense	-$24.68K	-$24.27K	-$21.14K
YoY Change	12.69%	14.81%	3.53%
% of Operating Profit
Other Income/Expense, Net		-$24.27K	$0.00
YoY Change			-100.0%
Pretax Income	-$115.9K	-$112.3K	$7.660K
YoY Change	-37.74%	-1566.21%	-103.47%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$116.6K	-$114.8K	$3.690K
YoY Change	-37.69%	-3211.3%	-101.86%
Net Earnings / Revenue	-42.97%	-37.04%	1.11%
Basic Earnings Per Share		-$0.01	-$0.01
Diluted Earnings Per Share	$0.00	-$3.588K	$122.10
COMMON SHARES
Basic Shares Outstanding	32.53M shares	31.99M shares	30.22M shares
Diluted Shares Outstanding		32.00M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$37.04K	$32.57K	$78.57K
YoY Change	-59.27%	-58.55%	4.84%
Cash & Equivalents	$37.04K	$32.57K	$78.57K
Short-Term Investments
Other Short-Term Assets	$75.65K	$99.12K	$85.10K
YoY Change	20.37%	16.47%	-8.35%
Inventory	$248.9K	$267.5K	$221.7K
Prepaid Expenses
Receivables	$156.2K	$180.6K	$176.9K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$517.8K	$579.8K	$562.2K
YoY Change	6.23%	3.13%	15.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$303.8K	$319.4K	$469.0K
YoY Change	-16.18%	-31.9%	-10.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.000K	$6.000K	$6.000K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$342.4K	$370.0K	$477.4K
YoY Change	-23.56%	-22.49%	-12.32%
TOTAL ASSETS
Total Short-Term Assets	$517.8K	$579.8K	$562.2K
Total Long-Term Assets	$342.4K	$370.0K	$477.4K
Total Assets	$860.2K	$949.8K	$1.040M
YoY Change	-8.04%	-8.64%	0.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$200.0K	$219.0K	$188.6K
YoY Change	-12.15%	16.13%	43.82%
Accrued Expenses	$2.638M	$2.636M	$2.259M
YoY Change	15.57%	16.67%	22.71%
Deferred Revenue
YoY Change
Short-Term Debt	$818.1K	$768.6K	$659.6K
YoY Change	27.79%	16.52%	-23.88%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.655M	$3.622M	$3.107M
YoY Change	16.03%	16.58%	9.07%
LONG-TERM LIABILITIES
Long-Term Debt	$146.3K	$147.1K	$150.0K
YoY Change	-2.5%	-1.95%
Other Long-Term Liabilities	$0.00	$0.00	$42.63K
YoY Change	-100.0%	-100.0%	-51.61%
Total Long-Term Liabilities	$146.3K	$147.1K	$192.6K
YoY Change	-19.01%	-23.65%	118.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.655M	$3.622M	$3.107M
Total Long-Term Liabilities	$146.3K	$147.1K	$192.6K
Total Liabilities	$3.801M	$3.769M	$3.300M
YoY Change	14.13%	14.23%	12.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$32.43M	-$32.31M
YoY Change	2.3%
Common Stock	$3.263K	$3.263K
YoY Change	5.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.033K	$1.033K
YoY Change	0.0%
Treasury Stock Shares	103.3K shares	103.3K shares
Shareholders Equity	-$2.941M	-$2.820M	-$2.260M
YoY Change
Total Liabilities & Shareholders Equity	$860.2K	$949.8K	$1.040M
YoY Change	-8.04%	-8.64%	0.99%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$116.6K	-$114.8K	$3.690K
YoY Change	-37.69%	-3211.3%	-101.86%
Depreciation, Depletion And Amortization	$15.33K	$14.56K	$18.39K
YoY Change	-13.73%	-20.83%	26.39%
Cash From Operating Activities	-$33.36K	-$76.74K	-$62.39K
YoY Change	-206.07%	23.0%	-61.89%
INVESTING ACTIVITIES
Capital Expenditures	-$320.00	$100.00	-$6.450K
YoY Change	-203.23%	-101.55%	-36.39%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change			-100.0%
Cash From Investing Activities	$320.00	$100.00	-$6.450K
YoY Change	3.23%	-101.55%	3294.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	37.50K	65.60K	38.73K
YoY Change	-293.4%	69.38%	-76.93%
NET CHANGE
Cash From Operating Activities	-33.36K	-76.74K	-62.39K
Cash From Investing Activities	320.0	100.0	-6.450K
Cash From Financing Activities	37.50K	65.60K	38.73K
Net Change In Cash	4.460K	-11.04K	-30.11K
YoY Change	-63.95%	-63.33%	-864.21%
FREE CASH FLOW
Cash From Operating Activities	-$33.36K	-$76.74K	-$62.39K
Capital Expenditures	-$320.00	$100.00	-$6.450K
Free Cash Flow	-$33.04K	-$76.84K	-$55.94K
YoY Change	-206.1%	37.36%	-63.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	VYCO	Forgiveness Of Debt Paycheck Protection Program ForgivenessOfDebtPaycheckProtectionProgram		usd
	VYCO	Forgiveness Of Debt Paycheck Protection Program ForgivenessOfDebtPaycheckProtectionProgram		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001424768
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
	VYCO	Forgiveness Of Debt Paycheck Protection Program ForgivenessOfDebtPaycheckProtectionProgram		usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue		usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue		usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue		usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue		usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold		usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold		usd
	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold		usd
	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold		usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss		usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss		usd
	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss		usd
	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss		usd
CY2022Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
CY2021Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	VYCOR MEDICAL, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity File Number EntityFileNumber	001-34932
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-3369218
	dei	Entity Address Address Line1 EntityAddressAddressLine1	951 Broken Sound Parkway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 320
	dei	Entity Address City Or Town EntityAddressCityOrTown	Boca Raton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33487
	dei	City Area Code CityAreaCode	(561)
	dei	Local Phone Number LocalPhoneNumber	558-2020
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	VYCO
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32527172	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32570	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	90941	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	180558	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	126096	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	267542	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	207521	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	98244	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	62473	usd
CY2022Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	880	usd
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	380	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	579794	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	487411	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	319422	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	362393	usd
CY2022Q3	us-gaap	Security Deposit SecurityDeposit	6000	usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	6000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	44600	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79560	usd
CY2022Q3	VYCO	Intangible And Other Asset Total IntangibleAndOtherAssetTotal	50600	usd
CY2021Q4	VYCO	Intangible And Other Asset Total IntangibleAndOtherAssetTotal	85560	usd
CY2022Q3	us-gaap	Assets Assets	949816	usd
CY2021Q4	us-gaap	Assets Assets	935364	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	219007	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	227720	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	413091	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	380479	usd
CY2022Q3	VYCO	Accrued Interest Related Party AccruedInterestRelatedParty	134700	usd
CY2021Q4	VYCO	Accrued Interest Related Party AccruedInterestRelatedParty	106444	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	97445	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	126959	usd
CY2022Q3	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	1946220	usd
CY2021Q4	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	1621850	usd
CY2022Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	337721	usd
CY2021Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	319329	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	430873	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	320873	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44600	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	46915	usd
CY2022Q3	VYCO	Liabilities Of Disposal Group Including Discontinued Operations Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationsCurrent	-1409	usd
CY2021Q4	VYCO	Liabilities Of Disposal Group Including Discontinued Operations Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationsCurrent	-572	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3622248	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3149997	usd
CY2022Q3	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	147070	usd
CY2021Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	150000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30580	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	147070	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	180580	usd
CY2022Q3	us-gaap	Liabilities Liabilities	3769318	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3330577	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	270307	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	270307	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	270307	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	270307	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	27	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	27	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	55000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	55000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32630506	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30921701	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32527172	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30818367	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	3263	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3092	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29360447	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29172169	usd
CY2022Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	103334	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	103334	shares
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue	1033	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1033	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32309881	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31697142	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	127675	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	127674	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2819502	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2395213	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	949816	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	935364	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	309969	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	332087	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	951725	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1119263	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	42199	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	35145	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	103493	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	102950	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	267770	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	296942	usd
	us-gaap	Gross Profit GrossProfit	848232	usd
	us-gaap	Gross Profit GrossProfit	1016313	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1825	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8454	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14559	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17728	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	43857	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	49275	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	341256	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	365785	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1019693	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1230340	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	355815	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	385338	usd
	us-gaap	Operating Expenses OperatingExpenses	1063550	usd
	us-gaap	Operating Expenses OperatingExpenses	1288069	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-88045	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-88396	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-215318	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-271756	usd
CY2022Q3	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	10351	usd
CY2021Q3	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	8088	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	28257	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	23753	usd
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	13511	usd
CY2021Q3	us-gaap	Interest Expense Other InterestExpenseOther	12685	usd
	us-gaap	Interest Expense Other InterestExpenseOther	39195	usd
	us-gaap	Interest Expense Other InterestExpenseOther	42465	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-405	usd
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-372	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1065	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1371	usd
CY2021Q3	VYCO	Forgiveness Of Debt Paycheck Protection Program ForgivenessOfDebtPaycheckProtectionProgram	117200	usd
	VYCO	Forgiveness Of Debt Paycheck Protection Program ForgivenessOfDebtPaycheckProtectionProgram	117200	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24267	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	96055	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-68517	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	49611	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-112312	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7659	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-283835	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-222145	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-112312	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	7659	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-283835	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-222145	usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2495	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-3966	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-4534	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-26455	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-114807	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	3693	usd
	us-gaap	Net Income Loss NetIncomeLoss	-288369	usd
	us-gaap	Net Income Loss NetIncomeLoss	-248600	usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	162185	usd
CY2021Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	162185	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	324370	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	324370	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-276992	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-158492	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-612739	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-572970	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-4	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-6	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-114806	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3697	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-288368	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-248594	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.00
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.00
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.01
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.01
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.00
CY2021Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.00
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.00
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.00
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31997281	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30219556	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31432040	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29249192	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2599297	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	56786	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-276992	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2819502	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2395213	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	176250	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12199	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-612739	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2819502	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-2178768	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	77142	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-158492	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-2260114	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1981316	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1981316	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	273166	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-572970	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-2260114	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-2260114	usd
	us-gaap	Net Income Loss NetIncomeLoss	-288369	usd
	us-gaap	Net Income Loss NetIncomeLoss	-248600	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8983	usd
	us-gaap	Depreciation Depreciation	46073	usd
	us-gaap	Depreciation Depreciation	41665	usd
	us-gaap	Inventory Write Down InventoryWriteDown	11360	usd
	us-gaap	Inventory Write Down InventoryWriteDown	9270	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	187381	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	284102	usd
	VYCO	Forgiveness Of Debt Paycheck Protection Program ForgivenessOfDebtPaycheckProtectionProgram	117200	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	54462	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17646	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	71381	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	49838	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	32638	usd
	us-gaap	Interest Paid Net InterestPaidNet	6579	usd
	us-gaap	Interest Paid Net InterestPaidNet	2193	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_806_eus-gaap--BasisOfAccounting_zCvmiWKwMkbh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_82C_zU2c3hsorSk">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements of Vycor Medical, Inc. (the “Company” or “Vycor”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities Exchange Commission. In accordance with those rules and regulations certain information and footnote disclosures normally included in consolidated financial statements have been omitted pursuant to such rules and regulations. The consolidated balance sheet as of December 31, 2021 derives from the audited financial statements at that date, but does not include all the information and footnotes required by GAAP. These unaudited consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited consolidated financial statements as of and for the three and nine months ended September 30, 2022 and 2021, in the opinion of management, include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the Company’s financial condition, results of operations and cash flows. The results of operations for the three and nine months ended September 30, 2022 and 2021 are not necessarily indicative of the results to be expected for any other interim period or for the entire year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ability to continue as a Going Concern</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred losses since its inception, including a net loss of $<span id="xdx_90F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iN_pp0p0_di_c20220101__20220930_z5H4NP3pb735" title="Net loss">612,739</span> for the nine months ended September 30, 2022 and has not generated sufficient positive cash flows from operations. As of September 30, 2022 the Company had a working capital deficiency of $<span id="xdx_904_ecustom--WorkingCapitalDeficiency_iI_pp0p0_c20220930_zLXFibe2NWLb" title="Working capital deficiency">530,661</span>, excluding related party liabilities of $<span id="xdx_906_eus-gaap--RelatedPartyDepositLiabilities_iI_pp0p0_c20220930_z1HYJPMQNYo3" title="Related party liabilities">2,511,793</span>. These conditions, among others, raise substantial doubt regarding our ability to continue as a going concern. The unaudited consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is executing on a plan to achieve a reduction in cash operating losses. Included within the working capital deficiency above is a term note for $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220930__dei--LegalEntityAxis__custom--EuroAmericanInvestmentCorpMember_zg6NVahUtHNh" title="Debt instrument, face amount">300,000</span> to EuroAmerican Investment Corp. (“EuroAmerican”), together with accrued interest of $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220930__dei--LegalEntityAxis__custom--EuroAmericanInvestmentCorpMember_zIseLjpiQvKe" title="Accrued interest">412,798</span>, which has a maturity date of March 31, 2023, having been extended on a number of occasions from its initial due date of June 11, 2011. At this time, it is not known whether any further extension of the note beyond March 31, 2023 will be available. However, the Company believes it may not have sufficient cash to meet its various cash needs through November 30, 2023 unless the Company is able to obtain additional cash from the issuance of debt or equity securities. Fountainhead, the Company’s largest shareholder, has provided working capital funding to the Company on an as-needed basis, although there is no guarantee that this will continue to be the case. The Company may consider seeking additional equity or debt funding, although there is no assurance that this would be available on acceptable terms or at all. If adequate funds are not available, the Company may have to delay or curtail development or commercialization of products, or cease some of its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-612739	usd
CY2022Q3	VYCO	Working Capital Deficiency WorkingCapitalDeficiency	530661	usd
CY2022Q3	us-gaap	Related Party Deposit Liabilities RelatedPartyDepositLiabilities	2511793	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2871	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8713	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9468	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	28256	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	23753	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	29682	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	40271	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-29514	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	6608	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1337	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-3791	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-183662	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10084	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3102	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	38690	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3102	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-38690	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	110000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	10000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	58600	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	18392	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	12740	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	128392	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81340	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-58371	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	32571	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	90941	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	46002	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32570	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	78573	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	880	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-4534	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-26455	usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2495	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-3966	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-4534	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-26455	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4666328	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4437757	shares
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	380	usd
CY2022Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	880	usd
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	380	usd
CY2022Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	880	usd
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	380	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent	4	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent	4	usd
CY2022Q3	VYCO	Disposal Group Including Discontinued Operations Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationsOtherCurrentLiabilities	-1413	usd
CY2021Q4	VYCO	Disposal Group Including Discontinued Operations Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationsOtherCurrentLiabilities	-576	usd
CY2022Q3	VYCO	Liabilities Of Disposal Group Including Discontinued Operations Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationsCurrent	-1409	usd
CY2021Q4	VYCO	Liabilities Of Disposal Group Including Discontinued Operations Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationsCurrent	-572	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	2420	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	3921	usd
	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	4413	usd
	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	25567	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	2420	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	3921	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	4413	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	25567	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-2420	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-3921	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-4413	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-25567	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	-75	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	-45	usd
	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	-121	usd
	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	-888	usd
CY2022Q3	VYCO	Disposal Group Including Discontinued Operation Other Income Expense DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense	-75	usd
CY2021Q3	VYCO	Disposal Group Including Discontinued Operation Other Income Expense DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense	-45	usd
	VYCO	Disposal Group Including Discontinued Operation Other Income Expense DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense	-121	usd
	VYCO	Disposal Group Including Discontinued Operation Other Income Expense DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense	-888	usd
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-2495	usd
CY2021Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-3966	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	430873	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	320873	usd
CY2022Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	337721	usd
CY2021Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	319329	usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	147070	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	150000	usd
CY2022Q3	VYCO	Operating Lease Right Of Use Assets Gross OperatingLeaseRightOfUseAssetsGross	44600	usd
CY2021Q4	VYCO	Operating Lease Right Of Use Assets Gross OperatingLeaseRightOfUseAssetsGross	79560	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	44600	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79560	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44600	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	46915	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	-0	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30580	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	44600	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	77495	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	309969	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	332087	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	951725	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1119263	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	267770	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	296942	usd
	us-gaap	Gross Profit GrossProfit	848232	usd
	us-gaap	Gross Profit GrossProfit	1016313	usd
CY2022Q3	us-gaap	Assets Assets	949816	usd
CY2021Q4	us-gaap	Assets Assets	935364	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	309969	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	332087	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	951725	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1119263	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	267770	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	296942	usd
	us-gaap	Gross Profit GrossProfit	848232	usd
	us-gaap	Gross Profit GrossProfit	1016313	usd
CY2022Q3	us-gaap	Assets Assets	949816	usd
CY2021Q4	us-gaap	Assets Assets	935364	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	680000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.28
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	680000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.28
	us-gaap	Payments For Rent PaymentsForRent	58666	usd
	us-gaap	Payments For Rent PaymentsForRent	58691	usd
CY2012Q2	VYCO	Sales And Excise Tax Payable Reduction Current And Noncurrent SalesAndExciseTaxPayableReductionCurrentAndNoncurrent	75000	eur
CY2012Q2	VYCO	Sales And Excise Tax Payable Reduction Current And Noncurrent SalesAndExciseTaxPayableReductionCurrentAndNoncurrent	82000	usd
CY2012Q2	us-gaap	Interest Expense InterestExpense	12000	eur
CY2012Q2	us-gaap	Interest Expense InterestExpense	13200	usd
CY2016Q4	VYCO	Sales And Excise Tax Payable Reduction Current And Noncurrent SalesAndExciseTaxPayableReductionCurrentAndNoncurrent	75000	eur
CY2016Q4	VYCO	Sales And Excise Tax Payable Reduction Current And Noncurrent SalesAndExciseTaxPayableReductionCurrentAndNoncurrent	82000	usd
CY2016Q4	us-gaap	Interest Expense InterestExpense	12000	eur
CY2016Q4	us-gaap	Interest Expense InterestExpense	13200	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	324370	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	324370	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1946220	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1621850	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	usd

Files In Submission

Name	View Source	Status
0001493152-22-031733-index-headers.html	Edgar Link	pending
R11.htm	Edgar Link	pending
0001493152-22-031733-index.html	Edgar Link	pending
0001493152-22-031733.txt	Edgar Link	pending
0001493152-22-031733-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vyco-20220930.xsd	Edgar Link	pending
vyco-20220930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
vyco-20220930_lab.xml	Edgar Link	unprocessable
vyco-20220930_pre.xml	Edgar Link	unprocessable
vyco-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VYCO
Vycor Medical Inc Stock $vyco

2022 Q4 Form 10-Q Financial Statement

#000149315222031733 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VYCO Vycor Medical Inc Stock $vyco

2022 Q4 Form 10-Q Financial Statement

#000149315222031733 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VYCO
Vycor Medical Inc Stock $vyco